Related Experiment Video
Updated: Mar 30, 2026
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
5.0K
Nanoliposomal Nitroglycerin Exerts Potent Anti-Inflammatory Effects
Soroush Ardekani1, Harry A Scott1, Sharad Gupta2
1Department of Bioengineering, University of California, Riverside, CA.
Scientific Reports
|November 21, 2015
Summary
Nitroglycerin (NTG) reduces inflammation by increasing nitric oxide (NO) and decreasing cell adhesion. A new NTG nanoformulation significantly boosts therapeutic effects and reduces side effects, offering potential for vascular normalization therapies.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Vascular Biology
Background:
- Nitroglycerin (NTG) enhances nitric oxide (NO) bioavailability, but its anti-inflammatory effects are unclear.
- Endothelial cell (EC) activation during inflammation contributes to vascular dysfunction.
- Developing effective NTG delivery systems is crucial for enhancing therapeutic efficacy and minimizing adverse effects.
Purpose of the Study:
- To investigate if NTG can suppress EC activation during inflammation.
- To develop and characterize a NTG nanoformulation (NTG-NL) for improved anti-inflammatory effects.
- To compare the therapeutic efficacy and safety of NTG-NL with free NTG.
Main Methods:
- Assessed NTG's effect on U937 cell adhesion to ECs using NO analyzer, microfluorimetry, and immunofluorescence staining.
- Formulated NTG-NL using unilamellar lipid vesicles and characterized particle size via dynamic light scattering.
- Quantified EC uptake of NTG-NL using quantitative fluorescence microscopy.
Main Results:
- NTG significantly inhibited U937 cell adhesion to ECs by increasing endothelial NO and reducing ICAM-1 clustering.
- NTG-NL, approximately 155 nm in diameter, was readily uptaken by ECs.
- NTG-NL demonstrated a 70-fold increase in therapeutic efficacy compared to free NTG and prevented excessive mitochondrial superoxide production.
Conclusions:
- NTG exhibits anti-inflammatory properties by suppressing EC activation.
- The developed NTG-NL is a promising nanoformulation with superior therapeutic efficacy and improved safety profile.
- NTG-NL warrants further investigation for potential application in vascular normalization therapies.
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
01:28Nitric Oxide Signaling Pathway
6.8K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K
01:23Antihypertensive Drugs: Vasodilators
2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.8K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K
01:18Drug Delivery: Enteral Route
2.5K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
2.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
607
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
607